- Geyser Brands is a cannabis consumer wellness company dedicated to helping people look, feel and do their best
- The company announced June 18 that wholly owned subsidiary Apothecary Botanicals has been awarded a processing license, allowing GYSR to advance its brands
- Geyser’s LOI to acquire Solace Management Group is expected to give the company additional wellness brands for humans and their pets, once due diligence is completed
Consumer wellness brand cultivator Geyser Brands Inc. (TSX.V: GYSR) is moving forward with its vision of developing premier cannabis-enhanced products following Health Canada’s announcement that the company’s wholly owned subsidiary, Apothecary Botanicals (0957102 B.C. Ltd.), has been awarded a coveted standard processing license.
“This is a huge milestone for Geyser Brands and something that we have been working towards for many months,” CEO Andreas Thatcher stated in a news release announcing Health Canada’s decision (http://ibn.fm/97gi1). “The license allows us to add value to existing consumer health care brands by providing them the platform to add CBD. It also reflects our business model to focus our Licensed Producer on delivering scale through manufacturing and distribution.”
Geyser Brands is a British Columbia-based company whose products leverage a proprietary NanoFusion technology to make bioavailable formulations for promoting human and pet health. In March, the company celebrated its first successful harvest of hemp test crops under the requirements of Health Canada’s license to cultivate cannabis, and, in May, GYSR began operations at its Apothecary Botanicals manufacturing facility.
Physical modifications to the facility to deliver GMP-compliant capacity are complete, according to the announcement, and Geyser expects to begin production of in-house formulated products for future branding of edibles, extracts and topicals at the facility within the next 30 days.
The new license allows Geyser to begin work to extend its cannabidiol products to the regulated Canadian consumer medical market as the company awaits its sales license. The company’s nano-emulsion technology carries oil and hemp terpene-infused benefits quickly and efficiently into the bloodstream for rapid relief of pain while boosting the body’s general abilities with all-natural ingredients.
In keeping with its mission to develop CBD products for the wellness market, Geyser is working to complete its due diligence following an LOI to acquire Solace Management Group Inc.’s brands and assets, which include hemp-based product line Apothecary Naturals, hemp-based tattoo after-care products Apothecary Ink, hemp oil pet treats under the Apawthecary Pets brand and WildTail Pets freeze-dried food products for dogs and cats.
Solace distributes the branded products to thousands of stores in Canada, Europe, the Caribbean and North America. The acquisition is subject to the necessary approvals from the respective boards, shareholders and TSX Venture Exchange.
The changes to the Apothecary Botanicals facility will also include a laboratory for research and development. With the modifications complete, the company anticipates receiving its R&D and sales licenses in the coming months.
For more information, visit the company’s website at www.GeyserBrands.com
NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.